Susquehanna Fundamental Investments’s Albireo Pharma Inc ALBO Stock Holding History

Susquehanna Fundamental Investments’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$400K	Hold	13,394	–	–	0.01%	1160
2021 Q4	$312K	Sell	13,394 -3,014	-18%	-$80.1K	0.01%	1108
2021 Q3	$512K	Sell	16,408 -3,780	-19%	-$117K	0.01%	1198
2021 Q2	$710K	Sell	20,188 -5,312	-21%	-$173K	0.01%	1017
2021 Q1	$899K	Buy	25,500 +2,499	+11%	+$92.3K	0.02%	935
2020 Q4	$863K	Buy	23,001 +2,101	+10%	+$76.4K	0.02%	912
2020 Q3	$697K	Buy	+20,900	New	+$609K	0.02%	762

Other funds holding ALBO

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Susquehanna Fundamental Investments's ALBO Position: Q1 2022 in Review

Susquehanna Fundamental Investments held its Albireo Pharma Inc (ALBO) position steady in Q1 2022 at 13,394 shares worth $400K. The position accounts for 0.01% of the portfolio, ranked #1160.

Susquehanna Fundamental Investments first reported a position in ALBO in Q3 2020 and has held it in 7 quarters since. The position peaked at $899K in Q1 2021. 109 funds tracked by Wall St. Rank hold ALBO as of Q1 2022.

Susquehanna Fundamental Investments held 13,394 shares of Albireo Pharma Inc worth $400K as of Q1 2022.
Susquehanna Fundamental Investments left its Albireo Pharma Inc share count unchanged in Q1 2022.
Albireo Pharma Inc made up 0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1160 holding.
Susquehanna Fundamental Investments first reported a position in Albireo Pharma Inc in Q3 2020 and has held it in 7 quarters since.
Susquehanna Fundamental Investments's Albireo Pharma Inc position peaked at $899K in Q1 2021.
109 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.